Humor and Quirks
Source : (remove) : Nigerian Tribune
RSS • JSON • XML • CSV
Humor and Quirks
Source : (remove) : Nigerian Tribune
RSS • JSON • XML • CSV

New Drug Pipeline for Parkinson's Treatment: Update on Drug Trials


  Copy link into your clipboard //humor-quirks.news-articles.net/content/2025/05 .. parkinson-s-treatment-update-on-drug-trials.html
  Print publication without navigation Published in Humor and Quirks on by
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source


  In recent years, the landscape of Parkinson's disease (PD) research has witnessed remarkable progress, offering new hope to the estimated 10 million people worldwide living with this neurod…

The article from Tribune Online discusses recent advancements in the treatment of Parkinson's disease, focusing on new drug pipelines and ongoing clinical trials. It highlights the development of BIIB122, a new drug by Biogen and Ionis Pharmaceuticals that targets the alpha-synuclein protein, showing promising results in early trials. Additionally, the article mentions the progress of tavapadon by Cerevel Therapeutics, which is designed to stimulate dopamine receptors and is currently in Phase 3 trials. Other drugs in development include nilotinib, which repurposes a cancer drug for Parkinson's, and ambroxol, which aims to increase glucocerebrosidase activity. The article emphasizes the importance of these trials in potentially offering new treatment options for Parkinson's patients, improving their quality of life.

Read the Full Nigerian Tribune Article at:
[ https://tribuneonlineng.com/new-drug-pipeline-for-parkinsons-treatment-update-on-drug-trials/ ]